Chiang Mai University — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Chiang Mai University appears in 37 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials37

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

37 shown

A Telenursing Program to Support Diabetes Self-ManagementNCT07366775 · lead sponsor · 2026-02-25

Theobromine From Cocoa and Cardiovascular Risk FactorsNCT06820944 · lead sponsor · 2025-02-15

Combined Physical-cognitive Exercise and Dietary Intervention for Postmenopausal Obese WomenNCT04768725 · lead sponsor · 2021-09-26

Early Sequential Nephron Blockade in Acute Heart Failure Patients: A Randomised, Controlled StudyNCT04465123 · lead sponsor · 2020-08-13

Furosemide Stress Test for the Prediction of Acute Kidney Injury Severity in Acute Heart Failure PatientsNCT04464811 · lead sponsor · 2020-07-05

Itraconazole Pharmacokinetic With and Without Efavirenz Using the Capsule Formulation as Part of Talaromycosis Treatment in HIV-infected AdultsNCT04031053 · lead sponsor · 2019-06-01

Neurocognitive Function Improvement After Switching From Efavirenz to RilpivirineNCT03567304 · lead sponsor · 2018-07-06

Immunologic Response of Hepatitis B VaccineNCT03219203 · lead sponsor · 2017-07-01

HBV Vaccination in HIV-infected AdultsNCT03212911 · lead sponsor · 2017-07-01

Efficacy of D-allulose on Weight and Fat Loss and Insulin Resistance in Non-diabetic Obese SubjectsNCT02988999 · lead sponsor · 2016-09-01

Acceptability of HIV Oral PrEP Among MSM and TGWNCT02855606 · lead sponsor · 2015-12-01

Calcium and High-dose Vitamin D Supplementation on Bone Mineral Density Among HIV-infected Children and AdolescentsNCT02426840 · lead sponsor · 2015-04-01

Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell CountsNCT02732054 · lead sponsor · 2015-03-01

Hepatitis B Vaccination in HIV-infected AdultsNCT02713620 · lead sponsor · 2015-01-01

Effect of NF-кB Dependent Proinflammation on Osteogenic Differentiation of the Mesenchymal Stem Cells in Type 2 DiabetesNCT02286128 · lead sponsor · 2014-11-01

Effects of DPP4 Inhibitor Versus SGLT2 InhibitorNCT03178591 · lead sponsor · 2014-10-01

Effectiveness of Buddhist Monks in Providing Cognitive Behavior TherapyNCT01706731 · lead sponsor · 2012-10-01

Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive DisorderNCT01682785 · lead sponsor · 2012-09-01

Prevalence of and Factors Associated With Metabolic Syndrome in SchizophreniaNCT01587521 · lead sponsor · 2012-01-01

Reliability and Validity of Thai Calgary Depression Scale of Schizophrenia (CDSS)NCT01590784 · lead sponsor · 2012-01-01

Cost-consequence Analysis of Parenchymal Stapling Device Versus Hand-sewing for Pulmonary Lobectomy in Lung DiseaseNCT01575314 · lead sponsor · 2011-11-01

Modified Relaxation (MR) Technique for Treating Hypertension in Postmenopausal WomenNCT01429662 · lead sponsor · 2011-08-01

MMR Vaccination Among HIV-infected AdultsNCT02724852 · lead sponsor · 2011-07-01

The Effect of Dexmedetomidine on Hemodynamic Response During Double Lumen Endotracheal IntubationNCT01289769 · lead sponsor · 2011-03-01

Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult SubjectsNCT01289106 · lead sponsor · 2011-01-01

Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected PatientsNCT01392430 · lead sponsor · 2009-06-01

miRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes PredictionNCT05632055 · lead sponsor · 2000-08-26

ACTIVE_NOT_RECRUITING

UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for ChildrenNCT05993767 · collaborator · 2024-12-11

Developing a Learning Health System for Primary Care in ThailandNCT06873243 · collaborator · 2024-11-01

ACTIVE_NOT_RECRUITING

Effectiveness of Health Literacy Enhancement Program Among Older Persons With Physical MultimorbidityNCT06313138 · collaborator · 2023-07-15

Pharmacokinetics and Safety of DolutegravIr in NeonateNCT05590325 · collaborator · 2022-09-12

Diabetes Self Management Education Programme in ThailandNCT03938233 · collaborator · 2020-03-01

Tenofovir Adherence to Rapidly Guide and Evaluate PrEP and HIV TherapyNCT03012607 · collaborator · 2017-01-01

Counseling and Reminders for Regular HIV and STIs ScreeningNCT02752152 · collaborator · 2015-12-09

ALternative TEnofovir Dosing in Adults With Moderate Renal Function ImpairmentNCT01671982 · collaborator · 2012-08-01

Second-line TherapyNCT01788891 · collaborator · 2011-01-01

Treatment of Cerebral Toxoplasmosis in HIV/AIDSNCT00367081 · collaborator · 2003-05-01

Drugs studied in this sponsor's trials

7 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Chiang Mai University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo2

dapagliflozin1

dexmedetomidine1

dolutegravir1

rilpivirine 25 MG1

Truvada1

vildagliptin1

placebo RxCUI 8375 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials dapagliflozin RxCUI 1488564 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dexmedetomidine RxCUI 48937 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dolutegravir RxCUI 1433868 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial rilpivirine 25 MG RxCUI 1102271 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial Truvada RxCUI 495430 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial vildagliptin RxCUI 596554 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor27

collaborator10

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.